Promote Sponsor
verified SJR 0,553 · Q2 • database Scopus / SJR & Web of Science indexed
Pharmacogenetics and Genomics
United States · Lippincott Williams and Wilk...
workspace_premium Q2 — Molecular Biology lock Subscription Unclaimed

Pharmacogenetics and Genomics

Pharmacogenetics and Genomics is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 154. It has an SJR impact factor of 0,553 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,553.

Pharmacogenetics and Genomics focuses its scope in these topics and keywords: cypa, cypc, genes, variation, response, adverse, influence, variants, ugtb, therapy, ...

ISSN: 1744-6872
Editorial: Lippincott Williams and Wilkins
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,553 Q2
H-index 154
Tasa de Aceptación pie_chart
22% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,553

H-index

154

Docs (year)

46

Docs 3y

95

Total refs

1642

Cites 3y

167

Citable 3y

91

Cites/Doc 2y

1.62

Ref/Doc

35.7

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals

View more

Vincristine pharmacogenomics

View more

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population

View more

CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects

View more

CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers

View more

CYP1A21*F contains the -163C>A substitution and is highly inducible

View more

CYP1A21*F contains the -163C >A substitution and is highly inducible

View more

Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity

View more

Comment on Xie et al.

View more

Codeine and morphine pathway

View more

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

View more

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

View more
SHOW MORE ARTICLES

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.

View more

A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure

View more

Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men

View more

Association between TAAR6 polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients

View more

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients

View more

Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease

View more

ADH4 intronic variations are associated with alcohol dependence

View more

Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy

View more

A systematic analysis and comparison of warfarin initiation strategies

View more

A possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese

View more

A pharmacogene database enhanced by the 1000 Genomes Project

View more

A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

View more

FAQS